Indication
Filoviridae infections
1 clinical trial
1 product
Clinical trial
A Phase 2, Open-label, Study to Evaluate the Safety and Immunogenicity of a Heterologous 2-dose Vaccination Regimen Using Ad26.ZEBOV, MVA-BN-Filo in Adults and Children Originally Enrolled in the Control Arm of the EBOVAC-Salone StudyStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Product
Ad26.ZEBOV, MVA-BN-Filo